Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled
Anna R. Hemnes, Marc Humbert
European Respiratory Review (2017) Vol. 26, Iss. 146, pp. 170093-170093
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension
Kelly Chin, Olivier Sitbon, Martin Doelberg, et al.
Journal of the American College of Cardiology (2021) Vol. 78, Iss. 14, pp. 1393-1403
Open Access | Times Cited: 124
Systems Analysis of the Human Pulmonary Arterial Hypertension Lung Transcriptome
Robert S. Stearman, Quan M. Bui, Gil Speyer, et al.
American Journal of Respiratory Cell and Molecular Biology (2018) Vol. 60, Iss. 6, pp. 637-649
Open Access | Times Cited: 115
BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGFβ responses and altered cell mechanics
Christian Hiepen, Jerome Jatzlau, Susanne Hildebrandt, et al.
PLoS Biology (2019) Vol. 17, Iss. 12, pp. e3000557-e3000557
Open Access | Times Cited: 98
Transcriptional profiling of lung cell populations in idiopathic pulmonary arterial hypertension
Didem Saygın, Tracy Tabib, Humberto E. Trejo Bittar, et al.
Pulmonary Circulation (2020) Vol. 10, Iss. 1, pp. 1-15
Open Access | Times Cited: 90
Phenotypes in pulmonary hypertension
Jason Weatherald, Anna R. Hemnes, Bradley A. Maron, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 3, pp. 2301633-2301633
Closed Access | Times Cited: 10
Pulmonary Hypertension: Molecular Mechanisms and Clinical Studies
Joseph Adu‐Amankwaah, Qiang You, Xinying Liu, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access | Times Cited: 1
Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice
Stephen Y. Chan, Lewis J. Rubin
European Respiratory Review (2017) Vol. 26, Iss. 146, pp. 170094-170094
Open Access | Times Cited: 80
Major lung complications of systemic sclerosis
Christopher P. Denton, Athol U. Wells, Gerry Coghlan
Nature Reviews Rheumatology (2018) Vol. 14, Iss. 9, pp. 511-527
Closed Access | Times Cited: 79
Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?
Mélanie Lambert, Véronique Capuano, Andrea Olschewski, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 3162-3162
Open Access | Times Cited: 73
TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension
Robert P. Frantz, Raymond L. Benza, Richard N. Channick, et al.
Pulmonary Circulation (2021) Vol. 11, Iss. 4, pp. 1-7
Open Access | Times Cited: 44
An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients
Barbara Ruaro, Francesco Salton, Elisa Baratella, et al.
Diagnostics (2022) Vol. 12, Iss. 3, pp. 616-616
Open Access | Times Cited: 23
Pulmonary arterial hypertension: Sex matters
Joshua P. Dignam, Smriti Sharma, Ioannis Stasinopoulos, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 7, pp. 938-966
Open Access | Times Cited: 14
Characterization and regulation of wild‐type and mutant TASK‐1 two pore domain potassium channels indicated in pulmonary arterial hypertension
Kevin P. Cunningham, Robyn G. Holden, Pilar Escribano Subías, et al.
The Journal of Physiology (2018) Vol. 597, Iss. 4, pp. 1087-1101
Open Access | Times Cited: 42
Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension
Hélène Le Ribeuz, Véronique Capuano, Barbara Girerd, et al.
Biomolecules (2020) Vol. 10, Iss. 9, pp. 1261-1261
Open Access | Times Cited: 37
m6A Modification-mediated GRAP Regulates Vascular Remodeling in Hypoxic Pulmonary Hypertension
Pengfei Liu, Aikai Zhang, Zheng Ding, et al.
American Journal of Respiratory Cell and Molecular Biology (2022) Vol. 67, Iss. 5, pp. 574-588
Closed Access | Times Cited: 19
Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?
Ayedh K. Alamri, L. Christy, John Ryan
Drugs (2023) Vol. 83, Iss. 7, pp. 577-585
Open Access | Times Cited: 11
Hypoxia promotes pulmonary vascular remodeling via HIF-1α to regulate mitochondrial dynamics.
Xi Chen, Jiamei Yao, Fang Xia, et al.
PubMed (2019) Vol. 16, Iss. 12, pp. 855-871
Closed Access | Times Cited: 34
Pericytes in the Lung
Chi F. Hung, Carole L. Wilson, Lynn M. Schnapp
Advances in experimental medicine and biology (2019), pp. 41-58
Closed Access | Times Cited: 32
Necrosis-Released HMGB1 (High Mobility Group Box 1) in the Progressive Pulmonary Arterial Hypertension Associated With Male Sex
Marina Zemskova, Nolan McClain, Maki Niihori, et al.
Hypertension (2020) Vol. 76, Iss. 6, pp. 1787-1799
Open Access | Times Cited: 28
S1P induces proliferation of pulmonary artery smooth muscle cells by promoting YAP-induced Notch3 expression and activation
Jian Wang, Xin Yan, Wei Feng, et al.
Journal of Biological Chemistry (2021) Vol. 296, pp. 100599-100599
Open Access | Times Cited: 25
YAP/TAZ as mechanobiological signaling pathway in cardiovascular physiological regulation and pathogenesis
Rakibul Islam, Zhongkui Hong
Mechanobiology in Medicine (2024) Vol. 2, Iss. 4, pp. 100085-100085
Open Access | Times Cited: 3
Emerging role of BMPs/BMPR2 signaling pathway in treatment for pulmonary fibrosis
Qinmao Ye, Sarah Taleb, Jing Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117178-117178
Open Access | Times Cited: 3
Female fibroblast activation is estrogen-mediated in sex-specific 3D-bioprinted pulmonary artery adventitia models
Mikala C. Mueller, Rachel Blomberg, Alicia E. Tanneberger, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Historical milestones and future horizons: exploring the diagnosis and treatment evolution of the pulmonary arterial hypertension in adults
Vicente Benavides-Córdoba, M. Palacios, Anton Vonk-Noordegraaf
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Female Fibroblast Activation Is Estrogen-Mediated in Sex-Specific 3D-Bioprinted Pulmonary Artery Adventitia Models
Mikala C. Mueller, Rachel Blomberg, Alicia E. Tanneberger, et al.
ACS Biomaterials Science & Engineering (2025)
Open Access
Page 1 - Next Page

Scroll to top